Discovery of Anilinopyrimidines as Dual Inhibitors of c-Met and VEGFR-2: Synthesis, SAR, and Cellular Activity

Por Zhan, Zhengsheng, Ai, Jing, Liu, Qiufeng, Ji, Yinchun, Chen, Tiantian, Xu, Yechun, Geng, Meiyu, Duan, Wenhu
Publicado em 2014

Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors

Por Lv, Yongcong, Li, Mengyuan, Liu, Ting, Tong, Linjiang, Peng, Ting, Wei, Lixin, Ding, Jian, Xie, Hua, Duan, Wenhu
Publicado em 2014

Discovery of Substituted 1H-Pyrazolo[3,4-b]pyridine Derivatives as Potent and Selective FGFR Kinase Inhibitors

Por Zhao, Bin, Li, Yixuan, Xu, Pan, Dai, Yang, Luo, Cheng, Sun, Yiming, Ai, Jing, Geng, Meiyu, Duan, Wenhu
Publicado no ACS Med Chem Lett (2016)

The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma

Por He, Di, Xu, Qin, Yan, Ming, Zhang, Ping, Zhou, Xiaojian, Zhang, Zhiyuan, Duan, Wenhu, Zhong, Laiping, Ye, Dongxia, Chen, Wantao
Publicado em 2009

Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities

Por Wang, Ying, Zhan, Zhengsheng, Jiang, Xifei, Peng, Xia, Shen, Yanyan, Chen, Fang, Ji, Yinchun, Liu, Weiren, Shi, Yinghong, Duan, Wenhu, Ding, Jian, Ai, Jing, Geng, Meiyu
Publicado no Oncotarget (2016)